BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, July 1, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Regulatory actions for Jan. 22, 2026

Jan. 22, 2026
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Gore, Guardant Health, Horiba, Onemednet.
Read More

Regulatory actions for Jan. 21, 2026

Jan. 21, 2026
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Akeso, Atossa, Bioxcel, Bpgbio, Capricor, Celcuity, Cogent, Daiichi, Dyne, Eli Lilly, Immunitybio, Iregene, Lantern, Mesoblast, Nanoscope, Novartis, Organon, Rein, Valneva.
Read More

Other news to note for Jan. 21, 2026

Jan. 21, 2026
Biopharma happenings, including deals and partnerships, and other news in brief: Aicuris, Alteogen, Aspect, Boundless Bio, GSK, Guardant Health, Hyloris, Merck, Novo Nordisk, Orion, Pfizer, Shionogi, Smartbax, Tesaro, Viiv.
Read More

In the clinic for Jan. 21, 2026

Jan. 21, 2026
Clinical updates, including data readouts and publications: Biovaxys, Corvus, Genmab, Moderna, Nasus, Nxera, Phio, Reunion.
Read More

Financings for Jan. 21, 2026

Jan. 21, 2026
Biopharmas raising money in public or private financings, including: Agomab, DBV, Harbour, Metavia, Spyglass.
Read More

Appointments and advancements for Jan. 21, 2026

Jan. 21, 2026
New hires and promotions in the biopharma industry, including: Artcline, Emmecell, Nxera, Orikine, Taiho, Vaximm.
Read More

Appointments and advancements for Jan. 21, 2026

Jan. 21, 2026
New hires and promotions in the med-tech industry, including: BrightInsight, BVI.
Read More

Financings for Jan. 21, 2026

Jan. 21, 2026
Med-tech firms raising money in public or private financings, including: Anteris, Medtronic.
Read More

Other news to note for Jan. 21, 2026

Jan. 21, 2026
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Brainsway, Cerevasc, Compremium, Lucid Diagnostics, QT Imaging, Venus Concept.
Read More

Regulatory actions for Jan. 21, 2026

Jan. 21, 2026
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aidoc, Machina Medical, Omnia Medical, Sonomotion, Surgentec, Truvian Health.
Read More
Previous 1 2 … 72 73 74 75 76 77 78 79 80 … 1815 1816 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 29, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 30, 2026
  • Illustration demonstrating gut-brain axis

    CINP 2026: Gut microbiota could predict antidepressant response

    BioWorld
    The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
  • Brain made of chip and circuits

    Ascending BCI systems deepen national security, ethical concerns

    BioWorld
    Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
  • Handshake, businessmen holding dollar sign, lightbulb

    Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal

    BioWorld
    A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing